Rational development of prophylactic HIV vaccines based on structural and regulatory proteinsMOOIJ, Petra; HEENEY, Jonathan Luke.Vaccine. 2001, Vol 20, Num 3-4, pp 304-321, issn 0264-410XArticle

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc ConsortiumBART, Pierre-Alexandre; GOODALL, Ruth; LILJESTRÖM, Peter et al.Vaccine. 2008, Vol 26, Num 25, pp 3153-3161, issn 0264-410X, 9 p.Article

Characterization of α-defensins plasma levels in Macaca fascicularis and correlations with virological parameters during SHIV89.6P_cy11experimental infectionBARONCELLI, Silvia; NEGRI, Donatella R. M; HEENEY, Jonathan et al.AIDS research and human retroviruses. 2007, Vol 23, Num 2, pp 287-296, issn 0889-2229, 10 p.Article

Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque modelSUH, You S; PARK, Ki S; STAHL-HENNIG, Christiane et al.Vaccine. 2006, Vol 24, Num 11, pp 1811-1820, issn 0264-410X, 10 p.Article

Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeysMAGGIORELLA, Maria Teresa; BARONCELLI, Silvia; TRIPICIANO, Antonella et al.Vaccine. 2004, Vol 22, Num 25-26, pp 3258-3269, issn 0264-410X, 12 p.Article

Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturallyONDOA, Pascale; DAVIS, David; WILLEMS, Betty et al.Journal of medical virology. 2001, Vol 65, Num 4, pp 765-776, issn 0146-6615Article

EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C aloneMCCORMACK, Sheena; STÖHR, Wolfgang; BURNET, Séverine et al.Vaccine. 2008, Vol 26, Num 25, pp 3162-3174, issn 0264-410X, 13 p.Article

Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaquesBRENNER, Matthias; MÜNCH, Jan; TEN HAAFT, Peter et al.Journal of virology. 2006, Vol 80, Num 9, pp 4469-4481, issn 0022-538X, 13 p.Article

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challengeNEGRI, Donatella R. M; BARONCELLI, Silvia; FARCOMENI, Stefania et al.Journal of general virology. 2004, Vol 85, pp 1191-1201, issn 0022-1317, 11 p., 5Article

An in vivo model for HIV resistance developmentZUBER, Bartek; BÖTTIGER, Disa; BENTHIN, Reinhold et al.AIDS research and human retroviruses. 2001, Vol 17, Num 7, pp 631-635, issn 0889-2229Article

A novel simian immunodeficiency virus isolated from a Schmidt's guenon (Cercopithecus ascanius schmidti)VERSCHOOR, Ernst J; FAGROUCH, Zahra; BONTJER, Ilja et al.Journal of general virology. 2004, Vol 85, pp 21-24, issn 0022-1317, 4 p., 1Article

Vaccine protection from CD4⁺ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigensKOOPMAN, Gerrit; MORTIER, Daniella; HOFMAN, Sam et al.Journal of general virology. 2004, Vol 85, pp 2915-2924, issn 0022-1317, 10 p., 10Article

The phylogeography of orangutan foamy viruses supports the theory of ancient repopulation of SumatraVERSCHOOR, Ernst J; LANGENHUIJZEN, Susan; BONTJER, Ilja et al.Journal of virology. 2004, Vol 78, Num 22, pp 12712-12716, issn 0022-538X, 5 p.Article

Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaquesROSENWIRTH, Brigitte; KUHN, Eva-Maria; HEENEY, Jonathan L et al.Vaccine. 2001, Vol 19, Num 13-14, pp 1661-1670, issn 0264-410XConference Paper

Molecular characterization of the first polyomavirus from a New World primate : squirrel monkey polyomavirusVERSCHOOR, Ernst J; GROENEWOUD, Marlous J; FAGROUCH, Zahra et al.Journal of general virology. 2008, Vol 89, pp 130-137, issn 0022-1317, 8 p., 1Article

Long-term persistence of HIV-1 vaccine-induced CD4⁺CD45 RA^-CD62l^-CCR7^- memory T-helper cellsBALLA-JHAGJHOORSINGH, Sunita S; KOOPMAN, Gerrit; MOOIJ, Petra et al.AIDS (London). 2004, Vol 18, Num 6, pp 837-848, issn 0269-9370, 12 p.Article

Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairmentROLLIER, Christine; DREXHAGE, Joost A. R; VERSTREPEN, Babs E et al.Hepatology (Baltimore, Md.). 2003, Vol 38, Num 4, pp 851-858, issn 0270-9139, 8 p.Article

Readily acquired secondary infections of human and simian immunodeficiency viruses following single intravenous exposure in non-human primatesTEN HAAFT, Peter; VERSCHOOR, Ernst J; VERSTREPEN, Babs et al.Journal of general virology. 2004, Vol 85, pp 3735-3745, issn 0022-1317, 11 p., 12Article

Characterization of novel polyomaviruses from Bornean and Sumatran orang-utansGROENEWOUD, Marlous J; FAGROUCH, Zahra; VAN GESSEL, Sabine et al.Journal of general virology. 2010, Vol 91, pp 653-658, issn 0022-1317, 6 p., 3Article

Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomerKRASHIAS, George; SIMON, Anna-Katharina; WEGMANN, Frank et al.Vaccine. 2010, Vol 28, Num 13, pp 2482-2489, issn 0264-410X, 8 p.Article

Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization : increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combinationKOOPMAN, Gerrit; MORTIER, Daniella; VOSS, Gerald et al.Journal of general virology. 2008, Vol 89, pp 540-553, issn 0022-1317, 14 p., 2Article

No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replicationNIEUWENHUIS, Ivonne; BEENHAKKER, Niels; BOGERS, Willy M. J. M et al.Journal of general virology. 2010, Vol 91, pp 2974-2984, issn 0022-1317, 11 p., 12Article

Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitopeSHARPE, Sally A; COPE, Alethea; CRANAGE, Martin et al.Journal of general virology. 2004, Vol 85, pp 2591-2602, issn 0022-1317, 12 p., 9Article

Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp 120DAVIS, David; DONNERS, Helen; WILLEMS, Betty et al.Vaccine. 2004, Vol 22, Num 5-6, pp 747-754, issn 0264-410X, 8 p.Article

Clearance of Genotype lb Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing AntibodiesVERSTREPEN, Babs E; DEPLA, Erik; COSSET, Frangois L et al.The Journal of infectious diseases. 2011, Vol 204, Num 6, pp 837-844, issn 0022-1899, 8 p.Article